The Role of Stillbirth Prevention and Late Preterm (Near-Term) Births

2006 ◽  
Vol 30 (1) ◽  
pp. 20-23 ◽  
Author(s):  
Gary D.V. Hankins ◽  
Monica Longo
Keyword(s):  
2006 ◽  
Vol 33 (4) ◽  
pp. 777-792 ◽  
Author(s):  
Young Mi Lee ◽  
Jane Cleary-Goldman ◽  
Mary E. D'Alton

2016 ◽  
Vol 102 (2) ◽  
pp. 194-198 ◽  
Author(s):  
Jane V Gill ◽  
Elaine M Boyle

Most research on outcomes of preterm birth has centred on babies born at <32 weeks gestation and at highest risk of mortality and serious morbidity. Recent years have seen a dramatic increase in studies focusing on late preterm infants (34–36 weeks gestation). Early epidemiological studies demonstrated increased risks of mortality and adverse neonatal outcomes in this group, prompting further investigations. These increased risks have been confirmed and more recent studies have also included babies born at 37–38 weeks, now defined as ‘early-term’ births. It now seems that it is inappropriate to consider term and preterm as a dichotomy; gestational age rather represents a continuum in which risk and severity of adverse outcomes increase with decreasing gestational age, but where measurable effects can be detected even very close to full term. In this review, we summarise current evidence for the outcomes of infants born at late preterm and early-term gestations.


2006 ◽  
Vol 33 (4) ◽  
pp. 751-763 ◽  
Author(s):  
Tonse N.K. Raju
Keyword(s):  

Author(s):  
Ram Kanwar Deora ◽  
Nikhila G. Shetty

Background: The objective of the study was to evaluate efficacy and safety of oral mifepristone for preinduction cervical ripening and induction of labour in late preterm and term pregnancies with previous caesarean section with intrauterine fetal demiseMethods: This prospective short term study was conducted at Umaid hospital SNMC Jodhpur Rajasthan January 2016 to November 2016. 100 subjects with previous uses beyond 34 week with intrauterine fetal demise and bishop’s score<6 were included. Tablet mifepristone 200mg was given orally after taking written in informed consent. The same dose was repeated after 24 hour according to bishop’s score. Analysis was done with respect to maternal outcome of vaginal delivery, CS, duration of labour.Results: Among 100 subjects, 97 delivered vaginally (97%) delivered within 72 hour of 1% dose. Improvement of bishop’s score was observed in 1 subject (1%), which later required augmentation by oxytocin followed by vaginal delivery.1 subject (2%) failed to respond and required caesarean section, 72 hour after given of 1st dose.Conclusions: Mifepristone can be used safely and effectively for induction of labour in previous one and two LSCS near term and term pregnancies to avoid CS rates.


PEDIATRICS ◽  
2007 ◽  
Vol 119 (3) ◽  
pp. e659-e665 ◽  
Author(s):  
P. C. Young ◽  
T. S. Glasgow ◽  
X. Li ◽  
G. Guest-Warnick ◽  
G. Stoddard
Keyword(s):  

Resuscitation ◽  
2010 ◽  
Vol 81 (3) ◽  
pp. 327-330 ◽  
Author(s):  
Vincenzo Zanardo ◽  
Gary Weiner ◽  
Massimo Micaglio ◽  
Nicoletta Doglioni ◽  
Ramona Buzzacchero ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document